Povorcitinib |
INCB-54707; INCB54707; INCB054707; INCB-054707 |
Phase 3 Clinical |
Incyte Corp |
Pruritus; Renal Insufficiency; Chronic Urticaria; Kidney Diseases; Asthma; Urticaria; Prurigo; Hidradenitis Suppurativa; Angioedema; Vitiligo |
Details
|
Brepocitinib |
PF-06700841-15; PF-6700841; PF-841; PF-06700841 |
Phase 3 Clinical |
Pfizer Inc |
Alopecia; Dermatomyositis; Alopecia Areata; Kidney Diseases; Lupus Erythematosus, Systemic; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic; Hidradenitis Suppurativa; Uveitis, Posterior; Crohn Disease; Dermatitis, Atopic; Vitiligo; Panuveitis |
Details
|
WXFL-10203614 |
WXFL-10203614 |
Phase 3 Clinical |
Wuxi Fuxin Pharmaceutical Research And Development Co Ltd, Wuxi Apptec Co Ltd |
Arthritis, Rheumatoid; Colitis, Ulcerative; Dermatitis, Atopic |
Details
|
TLL-018 |
TLL-018 |
Phase 3 Clinical |
Tll Pharmaceutical Llc |
Chronic Urticaria; Arthritis, Rheumatoid; Psoriasis; Lupus Erythematosus, Systemic; Urticaria; Colitis, Ulcerative; Dermatitis, Atopic; Plaque psoriasis |
Details
|
Tinengotinib |
TT-00420; TT 00420; TT00420 |
Phase 3 Clinical |
TransThera Sciences (Nanjing) Inc |
Biliary Tract Neoplasms; Solid tumours; Kidney Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Triple Negative Breast Neoplasms; Small Cell Lung Carcinoma; Carcinoma, Transitional Cell; Urinary Bladder Neoplasms; Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms; Breast Neoplasms; Cholangiocarcinoma; Sarcoma; Thyroid Neoplasms; Gallbladder Neoplasms |
Details
|
LW-402 |
LW-402 |
Phase 3 Clinical |
Shanghai Longwood Biopharmaceuticals Co Ltd |
Arthritis, Rheumatoid; Vitiligo; Dermatitis, Atopic |
Details
|
LNK-01001 |
LNK001; LNK-207; EQ-121; LNK-01001; LNK01001; LNK-001 |
Phase 3 Clinical |
Lynk Pharmaceutical (Hangzhou) Co Ltd |
Non-radiographic axial spondyloarthritis; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Dermatitis, Atopic |
Details
|
Itacitinib |
INCB-039110-adipate; INCB-39110; INCB-039110; IBI-377 |
Phase 3 Clinical |
Incyte Corp |
Leukemia, Myeloid, Acute; Sarcoma, Synovial; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Hemic and Lymphatic Diseases; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Breast Neoplasms; Psoriasis; Thrombocytosis; Sarcoma; Leukemia, B-Cell; Primary Myelofibrosis; Colorectal Neoplasms; Asthma; Colitis, Ulcerative; Liposarcoma; Lymphoma; Lymphoma, Non-Hodgkin; Leukemia, Prolymphocytic, T-Cell; Lung Neoplasms; Lymphohistiocytosis, Hemophagocytic; Endometrial Neoplasms; Carcinoma, Hepatocellular; Myelodysplastic-Myeloproliferative Diseases; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Liposarcoma, Myxoid; Melanoma; Graft vs Host Disease; Leukemia; Leukemia, Myelogenous, Chronic; Lymphoma, B-Cell; Bronchiolitis Obliterans; Head and Neck Neoplasms; Cytokine Release Syndrome; Solid tumours; Chondrosarcoma; Leiomyosarcoma; Pruritus; Polycythemia Vera; Carcinoma, Renal Cell; Hematologic Neoplasms; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Myeloproliferative Disorders; Hodgkin Disease; N |
Details
|
PG-011 |
PG-011 |
Phase 2 Clinical |
Prime Gene Therapeutics Co Ltd |
Radiodermatitis; Epidermolysis Bullosa; Dermatitis; Rhinitis, Allergic; Prurigo; Eye Diseases; Dermatitis, Atopic; Vitiligo |
Details
|
WXSH-0150 |
WXSH-0150; TUL-01101 |
Phase 2 Clinical |
Zhuhai United Laboratories Co Ltd |
Arthritis, Rheumatoid; Dermatitis, Atopic |
Details
|
Elsubrutinib/Upadacitinib |
ABBV-599 |
Phase 2 Clinical |
Abbvie Inc |
Arthritis, Rheumatoid; Lupus Erythematosus, Systemic |
Details
|
NS-229 |
NS-229 |
Phase 2 Clinical |
Neurosearch As |
Eosinophilic Granulomatosis With Polyangiitis; Epilepsy |
Details
|
ATI-502 |
A-301; ATI-502; ATI-50002 |
Phase 2 Clinical |
Rigel Pharmaceuticals Inc |
Alopecia; Alopecia Areata; Dermatitis, Atopic |
Details
|
TDM-180935 |
TDM-180935 |
Phase 2 Clinical |
Jiaxing TechnoDerma Medicines Inc |
Dermatitis, Atopic |
Details
|
AC-201 |
AC-201 |
Phase 2 Clinical |
Accro Bioscience (Suzhou) Co Ltd |
Lupus Erythematosus, Systemic; Psoriasis |
Details
|
VVN-461 |
VVN461e; VVN-461-e; VVN-461 |
Phase 2 Clinical |
VivaVision Biotech Inc |
Uveitis, Anterior; Uveitis; Inflammation; Postoperative inflammation |
Details
|
Fingolimod/Tofacitinib |
FMX-114 |
Phase 2 Clinical |
Vyne Therapeutics Inc |
Dermatitis, Atopic |
Details
|
QY201 |
QY-201; QY201 |
Phase 2 Clinical |
E-nitiate Biopharmaceuticals (Hangzhou) Co Ltd |
Alopecia Areata; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Psoriasis; Prurigo; Dermatitis, Atopic |
Details
|
VC-005 |
VC-005 |
Phase 2 Clinical |
Jiangsu Vcare Pharmatech Co Ltd |
Inflammatory Bowel Diseases; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Joint Diseases; Colitis, Ulcerative; Dermatitis, Atopic; Vitiligo; Crohn Disease; Eczema |
Details
|
AZD-4604 |
AZD-4604 |
Phase 2 Clinical |
Astrazeneca Plc |
Asthma |
Details
|
ICP-332 |
ICP-332 |
Phase 2 Clinical |
InnoCare Pharma Ltd |
Psoriasis; Dermatitis, Atopic |
Details
|
ATI-1777 |
|
Phase 2 Clinical |
Aclaris Therapeutics Inc |
Dermatitis, Atopic |
Details
|
ATI-501 |
A-201; ATI-501; ATI-50001 |
Phase 2 Clinical |
Rigel Pharmaceuticals Inc |
Alopecia |
Details
|
CS-12192 |
CS12192 |
Phase 1 Clinical |
Shenzhen Chipscreen Biosciences Co Ltd |
Enteritis; Alopecia Areata; Graft vs Host Disease; Autoimmune Diseases; Multiple Sclerosis; Lupus Erythematosus, Systemic; Dermatitis, Atopic |
Details
|
FZJ-003 |
FZJ-003 |
Phase 1 Clinical |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd |
Arthritis, Rheumatoid; Dermatitis, Atopic |
Details
|
VR-588 |
VR-588; KN-002; KN-002 (Kinaset Therapeutics/Vectura) |
Phase 1 Clinical |
Vectura Ltd |
Asthma |
Details
|
GLPG-3121 |
GLPG-3121 |
Phase 1 Clinical |
Galapagos Nv |
|
Details
|
Tofacitinib oral (Biora Therapeutics) |
BT-600; PGN-600 |
Phase 1 Clinical |
Progenity Inc |
Colitis, Ulcerative |
Details
|
Tofacitinib citrate (TWi Biotechnology) |
AC-1101; IMG 003 |
Phase 1 Clinical |
Twi Biotechnology Inc |
Granuloma Annulare |
Details
|
GDC-0214 |
RG-6151; GDC-0214 |
Phase 1 Clinical |
Genentech Inc |
Asthma |
Details
|
BHV-8000 |
TLL-041; TLL041 |
Phase 1 Clinical |
Hangzhou Highlightll Pharmaceutical Co Ltd |
Multiple Sclerosis; Alzheimer Disease; Parkinson Disease; Central Nervous System Diseases |
Details
|
AQ-280 |
AQ-280 |
Phase 1 Clinical |
Aqilion AB |
Eosinophilic Esophagitis |
Details
|
PG-018 |
PG-018 |
Phase 1 Clinical |
Prime Gene Therapeutics Co Ltd |
Nephrosis; Glomerulonephritis, Membranous |
Details
|
MAX-40070 |
MAX-40070 |
Phase 1 Clinical |
Maxinovel Pty Ltd |
Alopecia Areata |
Details
|
H-018 |
H018; H-018 |
Phase 1 Clinical |
Jiangsu Carephar Pharmaceutical Co Ltd, Nanjing Shenzhou Jiamei Pharmaceutical Co Ltd |
Arthritis, Rheumatoid |
Details
|
TT-00420/Atezolizumab |
|
Phase 1 Clinical |
TransThera Sciences (Nanjing) Inc |
Gastrointestinal Neoplasms |
Details
|
LBG-1600M |
|
Phase 1 Clinical |
Suzhou Longbotai Pharmaceutical Co Ltd |
Dermatitis, Atopic |
Details
|
LNK-01002 |
LNK01002 |
Phase 1 Clinical |
Lynk Pharmaceutical (Hangzhou) Co Ltd |
Hematologic Neoplasms; Polycythemia Vera; Myeloproliferative Disorders; Primary Myelofibrosis; Leukemia, Myeloid, Acute |
Details
|
NIP-046 |
NIP-046 |
Phase 1 Clinical |
National Institutes Of Pharmaceutical Research And Development Co Ltd |
Chronic Urticaria; Arthritis, Rheumatoid |
Details
|
Tofacitinib controlled release (Triastek) |
T-21; T21 |
Clinical |
Triastek Inc |
Colitis, Ulcerative |
Details
|
Povorcitinib |
INCB-54707; INCB54707; INCB054707; INCB-054707 |
Phase 3 Clinical |
Incyte Corp |
Pruritus; Renal Insufficiency; Chronic Urticaria; Kidney Diseases; Asthma; Urticaria; Prurigo; Hidradenitis Suppurativa; Angioedema; Vitiligo |
Details
|
Brepocitinib |
PF-06700841-15; PF-6700841; PF-841; PF-06700841 |
Phase 3 Clinical |
Pfizer Inc |
Alopecia; Dermatomyositis; Alopecia Areata; Kidney Diseases; Lupus Erythematosus, Systemic; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic; Hidradenitis Suppurativa; Uveitis, Posterior; Crohn Disease; Dermatitis, Atopic; Vitiligo; Panuveitis |
Details
|
WXFL-10203614 |
WXFL-10203614 |
Phase 3 Clinical |
Wuxi Fuxin Pharmaceutical Research And Development Co Ltd, Wuxi Apptec Co Ltd |
Arthritis, Rheumatoid; Colitis, Ulcerative; Dermatitis, Atopic |
Details
|
TLL-018 |
TLL-018 |
Phase 3 Clinical |
Tll Pharmaceutical Llc |
Chronic Urticaria; Arthritis, Rheumatoid; Psoriasis; Lupus Erythematosus, Systemic; Urticaria; Colitis, Ulcerative; Dermatitis, Atopic; Plaque psoriasis |
Details
|
Tinengotinib |
TT-00420; TT 00420; TT00420 |
Phase 3 Clinical |
TransThera Sciences (Nanjing) Inc |
Biliary Tract Neoplasms; Solid tumours; Kidney Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Triple Negative Breast Neoplasms; Small Cell Lung Carcinoma; Carcinoma, Transitional Cell; Urinary Bladder Neoplasms; Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms; Breast Neoplasms; Cholangiocarcinoma; Sarcoma; Thyroid Neoplasms; Gallbladder Neoplasms |
Details
|
LW-402 |
LW-402 |
Phase 3 Clinical |
Shanghai Longwood Biopharmaceuticals Co Ltd |
Arthritis, Rheumatoid; Vitiligo; Dermatitis, Atopic |
Details
|
LNK-01001 |
LNK001; LNK-207; EQ-121; LNK-01001; LNK01001; LNK-001 |
Phase 3 Clinical |
Lynk Pharmaceutical (Hangzhou) Co Ltd |
Non-radiographic axial spondyloarthritis; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Dermatitis, Atopic |
Details
|
Itacitinib |
INCB-039110-adipate; INCB-39110; INCB-039110; IBI-377 |
Phase 3 Clinical |
Incyte Corp |
Leukemia, Myeloid, Acute; Sarcoma, Synovial; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Hemic and Lymphatic Diseases; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Breast Neoplasms; Psoriasis; Thrombocytosis; Sarcoma; Leukemia, B-Cell; Primary Myelofibrosis; Colorectal Neoplasms; Asthma; Colitis, Ulcerative; Liposarcoma; Lymphoma; Lymphoma, Non-Hodgkin; Leukemia, Prolymphocytic, T-Cell; Lung Neoplasms; Lymphohistiocytosis, Hemophagocytic; Endometrial Neoplasms; Carcinoma, Hepatocellular; Myelodysplastic-Myeloproliferative Diseases; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Liposarcoma, Myxoid; Melanoma; Graft vs Host Disease; Leukemia; Leukemia, Myelogenous, Chronic; Lymphoma, B-Cell; Bronchiolitis Obliterans; Head and Neck Neoplasms; Cytokine Release Syndrome; Solid tumours; Chondrosarcoma; Leiomyosarcoma; Pruritus; Polycythemia Vera; Carcinoma, Renal Cell; Hematologic Neoplasms; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Myeloproliferative Disorders; Hodgkin Disease; N |
Details
|
PG-011 |
PG-011 |
Phase 2 Clinical |
Prime Gene Therapeutics Co Ltd |
Radiodermatitis; Epidermolysis Bullosa; Dermatitis; Rhinitis, Allergic; Prurigo; Eye Diseases; Dermatitis, Atopic; Vitiligo |
Details
|
WXSH-0150 |
WXSH-0150; TUL-01101 |
Phase 2 Clinical |
Zhuhai United Laboratories Co Ltd |
Arthritis, Rheumatoid; Dermatitis, Atopic |
Details
|
Elsubrutinib/Upadacitinib |
ABBV-599 |
Phase 2 Clinical |
Abbvie Inc |
Arthritis, Rheumatoid; Lupus Erythematosus, Systemic |
Details
|
NS-229 |
NS-229 |
Phase 2 Clinical |
Neurosearch As |
Eosinophilic Granulomatosis With Polyangiitis; Epilepsy |
Details
|
ATI-502 |
A-301; ATI-502; ATI-50002 |
Phase 2 Clinical |
Rigel Pharmaceuticals Inc |
Alopecia; Alopecia Areata; Dermatitis, Atopic |
Details
|
TDM-180935 |
TDM-180935 |
Phase 2 Clinical |
Jiaxing TechnoDerma Medicines Inc |
Dermatitis, Atopic |
Details
|
AC-201 |
AC-201 |
Phase 2 Clinical |
Accro Bioscience (Suzhou) Co Ltd |
Lupus Erythematosus, Systemic; Psoriasis |
Details
|
VVN-461 |
VVN461e; VVN-461-e; VVN-461 |
Phase 2 Clinical |
VivaVision Biotech Inc |
Uveitis, Anterior; Uveitis; Inflammation; Postoperative inflammation |
Details
|
Fingolimod/Tofacitinib |
FMX-114 |
Phase 2 Clinical |
Vyne Therapeutics Inc |
Dermatitis, Atopic |
Details
|
QY201 |
QY-201; QY201 |
Phase 2 Clinical |
E-nitiate Biopharmaceuticals (Hangzhou) Co Ltd |
Alopecia Areata; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Psoriasis; Prurigo; Dermatitis, Atopic |
Details
|
VC-005 |
VC-005 |
Phase 2 Clinical |
Jiangsu Vcare Pharmatech Co Ltd |
Inflammatory Bowel Diseases; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Joint Diseases; Colitis, Ulcerative; Dermatitis, Atopic; Vitiligo; Crohn Disease; Eczema |
Details
|
AZD-4604 |
AZD-4604 |
Phase 2 Clinical |
Astrazeneca Plc |
Asthma |
Details
|
ICP-332 |
ICP-332 |
Phase 2 Clinical |
InnoCare Pharma Ltd |
Psoriasis; Dermatitis, Atopic |
Details
|
ATI-1777 |
|
Phase 2 Clinical |
Aclaris Therapeutics Inc |
Dermatitis, Atopic |
Details
|
ATI-501 |
A-201; ATI-501; ATI-50001 |
Phase 2 Clinical |
Rigel Pharmaceuticals Inc |
Alopecia |
Details
|
CS-12192 |
CS12192 |
Phase 1 Clinical |
Shenzhen Chipscreen Biosciences Co Ltd |
Enteritis; Alopecia Areata; Graft vs Host Disease; Autoimmune Diseases; Multiple Sclerosis; Lupus Erythematosus, Systemic; Dermatitis, Atopic |
Details
|
FZJ-003 |
FZJ-003 |
Phase 1 Clinical |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd |
Arthritis, Rheumatoid; Dermatitis, Atopic |
Details
|
VR-588 |
VR-588; KN-002; KN-002 (Kinaset Therapeutics/Vectura) |
Phase 1 Clinical |
Vectura Ltd |
Asthma |
Details
|
GLPG-3121 |
GLPG-3121 |
Phase 1 Clinical |
Galapagos Nv |
|
Details
|
Tofacitinib oral (Biora Therapeutics) |
BT-600; PGN-600 |
Phase 1 Clinical |
Progenity Inc |
Colitis, Ulcerative |
Details
|
Tofacitinib citrate (TWi Biotechnology) |
AC-1101; IMG 003 |
Phase 1 Clinical |
Twi Biotechnology Inc |
Granuloma Annulare |
Details
|
GDC-0214 |
RG-6151; GDC-0214 |
Phase 1 Clinical |
Genentech Inc |
Asthma |
Details
|
BHV-8000 |
TLL-041; TLL041 |
Phase 1 Clinical |
Hangzhou Highlightll Pharmaceutical Co Ltd |
Multiple Sclerosis; Alzheimer Disease; Parkinson Disease; Central Nervous System Diseases |
Details
|
AQ-280 |
AQ-280 |
Phase 1 Clinical |
Aqilion AB |
Eosinophilic Esophagitis |
Details
|
PG-018 |
PG-018 |
Phase 1 Clinical |
Prime Gene Therapeutics Co Ltd |
Nephrosis; Glomerulonephritis, Membranous |
Details
|
MAX-40070 |
MAX-40070 |
Phase 1 Clinical |
Maxinovel Pty Ltd |
Alopecia Areata |
Details
|
H-018 |
H018; H-018 |
Phase 1 Clinical |
Jiangsu Carephar Pharmaceutical Co Ltd, Nanjing Shenzhou Jiamei Pharmaceutical Co Ltd |
Arthritis, Rheumatoid |
Details
|
TT-00420/Atezolizumab |
|
Phase 1 Clinical |
TransThera Sciences (Nanjing) Inc |
Gastrointestinal Neoplasms |
Details
|
LBG-1600M |
|
Phase 1 Clinical |
Suzhou Longbotai Pharmaceutical Co Ltd |
Dermatitis, Atopic |
Details
|
LNK-01002 |
LNK01002 |
Phase 1 Clinical |
Lynk Pharmaceutical (Hangzhou) Co Ltd |
Hematologic Neoplasms; Polycythemia Vera; Myeloproliferative Disorders; Primary Myelofibrosis; Leukemia, Myeloid, Acute |
Details
|
NIP-046 |
NIP-046 |
Phase 1 Clinical |
National Institutes Of Pharmaceutical Research And Development Co Ltd |
Chronic Urticaria; Arthritis, Rheumatoid |
Details
|
Tofacitinib controlled release (Triastek) |
T-21; T21 |
Clinical |
Triastek Inc |
Colitis, Ulcerative |
Details
|